TY - JOUR
T1 - Timing of Onset, Burden, and Postdischarge Mortality of Persistent Critical Illness in Scotland, 2005–2014
T2 - A Retrospective, Population-Based, Observational Study
AU - Shaw, Martin
AU - Viglianti, Elizabeth M.
AU - McPeake, Joanne
AU - Bagshaw, Sean M.
AU - Pilcher, David
AU - Bellomo, Rinaldo
AU - Iwashyna, Theodore J.
AU - Quasim, Tara
N1 - Funding Information:
Dr. McPeake’s institution received funding from The Institute of Healthcare Improvement studies Institute (PD-2019-02-16) and the Health Foundation. This work was supported by grants T32 HL7749-25 (to Dr. Viglianti), K12 HL138039 (to Dr. Iwashyna) from the National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute. Dr. Viglianti received support for article research from the NIH. Dr. Bagshaw received funding from Baxter and CNA Diagnostics. Dr. Iwashyna disclosed government work. Dr. Quasim’s institution received funding from the Health Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Publisher Copyright:
© 2020 The Authors. Published by Wolters Kluwer Health, Inc.
PY - 2020/4/20
Y1 - 2020/4/20
N2 - Objectives: We aimed to understand the prevalence, timing of onset, resource use, and long-term outcomes of patients who developed persistent critical illness in a national dataset. Design: Retrospective cohort. Using a physiologic risk adjustment model from ICU admission, we examined the relative ability of acute (related to reason for ICU presentation) and antecedent (demographics, comorbidities) characteristics to discriminate hospital mortality models. Persistent critical illness was defined as the point during an ICU stay when, at the population-level, patients' acute diagnoses and physiologic disturbance are no longer more accurate at discriminating who survives than are baseline demographics and comorbidity. We examined the change across ICU stay in the relative discrimination of those characteristics, and short-term (in-hospital and 30 d after admission) and medium-term (90 d after admission) survival. Finally, we analyzed the changes in the population definition of persistent critical illness over time. Setting: Patients admitted as level 3 to Scottish ICUs between 2005 and 2014. Patients: Seventy-two-thousand two-hundred fifty-three adult level 3 ICU admissions in 23 ICUs across Scotland. Interventions: None. Measurements and Main Results: The onset of persistent critical illness, occurs at an average of 5.0 days (95% CI, 3.9-6.4 d) across this dataset. The crossing point increased across the decade, by an average of 0.36 days (95% CI, 0.22-0.50 d) per year. In this dataset, 24,425 (33.8%) remained in the ICU long enough to meet this greater than 5-day definition of persistent critical illness. The care of such patients involved 72.3% ICU days used by any level 3 patient; 46.5% of all Scottish ICU bed-days were after day 5. Although rates of 30 days after admission survival rose dramatically during the decade under study, these rates were similar for those with shorter or longer ICU stays, as were the rates of 90-day survival among those who survived at least 30 days. Conclusions: Persistent critical illness occurred in one in three ICU patients in Scotland. These minority of patients accounted for disproportionate hospital resources but did not have worse 30- or 90-day postadmission survival.
AB - Objectives: We aimed to understand the prevalence, timing of onset, resource use, and long-term outcomes of patients who developed persistent critical illness in a national dataset. Design: Retrospective cohort. Using a physiologic risk adjustment model from ICU admission, we examined the relative ability of acute (related to reason for ICU presentation) and antecedent (demographics, comorbidities) characteristics to discriminate hospital mortality models. Persistent critical illness was defined as the point during an ICU stay when, at the population-level, patients' acute diagnoses and physiologic disturbance are no longer more accurate at discriminating who survives than are baseline demographics and comorbidity. We examined the change across ICU stay in the relative discrimination of those characteristics, and short-term (in-hospital and 30 d after admission) and medium-term (90 d after admission) survival. Finally, we analyzed the changes in the population definition of persistent critical illness over time. Setting: Patients admitted as level 3 to Scottish ICUs between 2005 and 2014. Patients: Seventy-two-thousand two-hundred fifty-three adult level 3 ICU admissions in 23 ICUs across Scotland. Interventions: None. Measurements and Main Results: The onset of persistent critical illness, occurs at an average of 5.0 days (95% CI, 3.9-6.4 d) across this dataset. The crossing point increased across the decade, by an average of 0.36 days (95% CI, 0.22-0.50 d) per year. In this dataset, 24,425 (33.8%) remained in the ICU long enough to meet this greater than 5-day definition of persistent critical illness. The care of such patients involved 72.3% ICU days used by any level 3 patient; 46.5% of all Scottish ICU bed-days were after day 5. Although rates of 30 days after admission survival rose dramatically during the decade under study, these rates were similar for those with shorter or longer ICU stays, as were the rates of 90-day survival among those who survived at least 30 days. Conclusions: Persistent critical illness occurred in one in three ICU patients in Scotland. These minority of patients accounted for disproportionate hospital resources but did not have worse 30- or 90-day postadmission survival.
KW - chronic critical illness
KW - cohort study
KW - persistent critical illness
KW - postdischarge mortality
KW - prolonged mechanical ventilation
UR - https://www.scopus.com/pages/publications/85104126890
U2 - 10.1097/CCE.0000000000000102
DO - 10.1097/CCE.0000000000000102
M3 - Article
C2 - 32426744
AN - SCOPUS:85104126890
SN - 2639-8028
VL - 2
JO - Critical Care Explorations
JF - Critical Care Explorations
IS - 4
M1 - E0102
ER -